Blood pressure control and comorbidity in a nephrology clinic

Journal of Nephrology

Volumn 17, Issue 6, 2004, Pages 808-812

  Triolo, Luigi ^a   Cattaruzza, Maria Sofia ^b   Sicoli, Rosa ^a   Ansali, Ferruccio ^a   Malaguti, Moreno ^a   Osborn, John ^b   Biagini, Marco ^a  

^a S Paolo Hospital ASL RMF   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chronic kidney disease; Comorbidity; Diabetes mellitus; Elderly; Hypertension; Proteinuria

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEPHROLOGY; OUTPATIENT; PATIENT REFERRAL; PREDICTION; PROTEINURIA; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; AGING; BLOOD PRESSURE; CHRONIC DISEASE; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY;

AGED; AGING; AMBULATORY CARE FACILITIES; BLOOD PRESSURE; CHRONIC DISEASE; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; NEPHROLOGY; REFERRAL AND CONSULTATION;

EID: 16644387560     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26: 60-9.
2. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46.
3. Weir MR, Maibach EW, Bakris GL, Black HR, Chawla P, Messerli FH, Neutel JM, Weber MA. Implications of a health lifestyle and medication analysis for improving hypertension control. Arch Intern Med 2000; 160: 481-90.
4. Mulrow PJ. Detection and control of hypertension in the population: the United States experience. Am J Hypertens 1998; 11: 744-6.
5. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957-63.
6. Julius S. Worldwide trends and shortcomings in the treatment of hypertension. Am J Hypertens 2000; 13 (suppl): S57-61.
7. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-13.
8. Grimm RH Jr, Margolis KL, Papademetriou VV, Cushman WC, Ford CE, Bettencourt J, Alderman MH, Basile JN, Black HR, DeQuattro VV, Eckfeldt J, Hawkins CM, Perry HM Jr, Proschan M. Baseline characteris tics of participants in the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). Hypertension 2001; 37: 19-27.
9. Hill MN, Sutton BS. Barriers to hypertension care and control. Curr Hypertens Rep 2000; 2: 445-50.
10. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162: 413-20i
11. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-86.
12. He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med 2002; 162: 1051-8.
13. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7th report. JAMA 2003; 289: 2560-72.
14. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension. J Hypertens 2003; 21: 1011-53.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new predicton equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.
16. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993; 153: 154-83.
17. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999; 138: 211-9.
18. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-64.
19. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10: 697-704.
20. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension 2001; 38: 809-14.
21. Fagard RH, Van Den Enden M, Leeman M, Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002; 20: 1297-302.
22. Qureshi AI, Suri MF, Guterman LR, Hopkins LN. Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2001; 161: 1621-8.
23. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646-61.
24. Brown MJ, Castaigne A, de Leeuw PW, Mancia G, Palmer CR, Rosenthal T, Ruilope LM. Influence of diabetes and type of hypertension on response to antihypertensive treatment. Hypertension 2000; 35: 1038-42.
25. United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.
26. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeld D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755-62.
27. Ruilope LM. Lessons from trials in hypertensive type 2 diabetic patients. Curr Hypertens Rep 2003; 5: 322-8.
28. Schwenger V, Ritz E. Audit of antihypertensive treatment in patients with renal failure. Nephrol Dial Transplant 1998; 13: 3091-5.
29. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994; 330: 877-84.
30. Schillaci G, Reboldi G, Verdecchia P. High-normal serum creatinine concentration is a predictors of cardiovascular risk in essential hypertension. Arch Intern Med 2001; 161: 886-91.
31. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, Granger CB, Ohman EM, Holmes DR Jr; GUSTO-IIb, GUSTO-III, PURSUIT. Global Use of strategies to open occluded coronary arteries. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy; PARAGON-A investigators. Platelet IIb/IIIa antagonism for the reduction of acute coronary syndrome events in a global organization network. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106: 974-80.
32. Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. Nephrol Dial Transplant 2002; 17 (suppl 11): S50-4.
33. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003; 139: 244-52.
34. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, Black HR, Hamilton BP, Holland J, Nwachuku C, Papademetriou V, Probstfield J, Wright JT Jr, Alderman MH, Weiss RJ, Piller L, Bettencourt J, Walsh SM; ALLHAT collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the anti-hypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens 2002; 4: 393-404.
35. Maue SK, Rivo ML, Weiss B, Farrelly EW, Browner-Strenger S. Effect of a primary care physician-focused, population-based approach to blood pressure control. Fam Med 2002; 34: 508-13.